5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 35.78▲ | 39.89▼ |
MA10 | N/A | N/A | N/A | 36.80▼ | 47.39▼ |
MA20 | N/A | N/A | N/A | 41.33▼ | 56.30▼ |
MA50 | N/A | N/A | N/A | 49.49▼ | 83.14▼ |
MA100 | N/A | N/A | N/A | 59.36▼ | 95.39▼ |
MA200 | N/A | N/A | N/A | 77.33▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -0.152▼ | -0.829▼ |
RSI | N/A | N/A | N/A | 31.891▼ | 26.107▼ |
STOCH | N/A | N/A | N/A | 20.588 | 17.920▼ |
WILL %R | N/A | N/A | N/A | -73.018 | -84.750▼ |
CCI | N/A | N/A | N/A | -46.101 | -147.791▼ |
Sunday, May 12, 2024 08:17 PM
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
|
Saturday, May 11, 2024 05:00 PM
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called croma which is an electrosurgical ...
|
Saturday, May 11, 2024 12:57 AM
Argentex Group PLC (AIM: AGFX) announces that David Winney, Chief Compliance and Risk Officer, on 7 May 2024 purchased 50,000 ordinary shares of £0.0001 each ("Ordinary Shares") in the Company at ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/05/24 | 35.10 | 37.00 | 35.10 | 36.55 | 77,956 |
14/05/24 | 36.00 | 37.00 | 35.00 | 37.00 | 302,671 |
13/05/24 | 34.00 | 36.00 | 34.00 | 35.75 | 257,173 |
10/05/24 | 33.50 | 36.812 | 33.464 | 36.00 | 2,414,599 |
09/05/24 | 34.90 | 34.90 | 32.625 | 33.60 | 505,189 |
08/05/24 | 35.10 | 36.90 | 33.00 | 34.40 | 1,085,043 |
07/05/24 | 36.80 | 37.973 | 35.005 | 37.00 | 1,772,827 |
03/05/24 | 35.90 | 37.70 | 32.33 | 36.80 | 6,844,335 |
02/05/24 | 46.20 | 47.97 | 35.00 | 35.90 | 10,082,931 |
01/05/24 | 44.90 | 45.45 | 44.40 | 45.00 | 172,593 |
|
|
||||
|
|
||||
|
|